Venture Capital

Kunpeng Capital

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Venture Capital

Stage Focus
Early Stage, Late Stage, Growth

Geographical Focus
China

Industries Focus

  • Technology
  • Healthcare
  • Consumer Goods
  • TMT
  • High-end Equipment Manufacturing
  • Biomedicine

Investor Details Founded: 2016

Kunpeng Capital is a Chinese venture capital firm investing in early-stage technology companies. The firm focuses on strategic emerging industries and future industries supported by national policies, such as high-end equipment manufacturing, consumer goods, biomedicine, and TMT. Kunpeng Capital was established in 2016 and has total assets exceeding RMB200 billion.

Kunpeng Capital's investment strategy emphasizes marketization, specialization, internationalization, and standardization. The firm is dedicated to serving the reform, development, and innovation of Shenzhen's state-owned assets and enterprises, aiming to promote the transformation and upgrading of state-owned assets and enterprises. The firm's core ability lies in M&A funds operation and long-term value creation, providing comprehensive financial services for the city's State-owned Assets Supervision and Administration Commission (SASAC).

The firm's portfolio includes investments in various sectors, including technology, healthcare, consumer goods, biomedicine, and TMT. Kunpeng Capital has made 18 investments, with notable exits including Suning.com and HONOR. The firm's team consists of senior investment professionals with an average of over 15 years of industry experience in leading financial institutions worldwide.

Kunpeng Capital's investment approach is driven by a mission to serve the reform, development, and innovation of Shenzhen's state-owned assets and enterprises, aiming to promote the transformation and upgrading of state-owned assets and enterprises. The firm's core ability lies in M&A funds operation and long-term value creation, providing comprehensive financial services for the city's State-owned Assets Supervision and Administration Commission (SASAC).

Requirements
  • Focus on strategic emerging industries and future industries supported by national policies
  • Emphasis on high-end equipment manufacturing, consumer goods, biomedicine, and TMT sectors
  • Alignment with Shenzhen's state-owned assets and enterprises transformation and upgrading objectives
Contact

[Official Website Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • Ouye Semiconductor
  • Aerospace Times Feipeng
  • ZSE
  • OptoMedic
  • Signalwing
  • Ligatech Bioscience
  • Sinovation Medical
  • China Reserve National Energy
  • Haiguo Tuzhi
Claim this Investor

Are you an official representative of Kunpeng Capital?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim